A unifying hypothesis for the mechanism of NSAID related gastrointestinal toxicity

Annals of the Rheumatic Diseases

Volumn 55, Issue 4, 1996, Pages 211-213

  Mahmud, T ^a,c   Scott, D L ^a   Bjarnason, I ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Department of Clinical Biochemistry ^*

^c S Thames Regional Health Authority   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ETODOLAC; FENBUFEN; FLURBIPROFEN; INDOMETACIN; NABUMETONE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROSTAGLANDIN SYNTHASE; SULINDAC;

DRUG MECHANISM; ENZYME ACTIVITY; GASTROINTESTINAL TOXICITY; HUMAN; MITOCHONDRION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0029916285     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.55.4.211     Document Type: Short Survey

References (31)

1. Vane J. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971; 231: 232.
2. Bjarnason I, Hayllar J, Macpherson A J, Russell A. Side-effects of non-steroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993; 104: 1832-7.
3. Somasundaram S, Hayllar J, Rafi S, Wrigglesworth J M, Macpherson A J S, Bjarnason I. The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastro-intestinal tract: a review and a hypothesis. Scand J Gasteroenterol 1995; 30: 289-99.
4. Somasundaram S, Macpherson A J, Hayllar J, Sarathchandra P, Bjarnason I. Enterocyte mitochondrial damage due to NSAID in the rat. Gut 1992; 33 (suppl): S5.
5. Kasbekar D K. Effects of salicylate and related compounds on gastric HCl secretions. Am J Physiol 1973; 225: 521-7.
6. Madara J L, Nash S, Moore R, Atisook K. Structure and function of the intestinal epithelial barrier in health and disease. Monogr Pathol 1990; 31: 306-24.
7. Mahmud T, Rafi S, Scott D L, Wrigglesworth J M, Bjarnason I. Uncoupling of oxidative phosphorylation by NSAIDs relates to their pKa. Br J Rheumatol 1995; 34 (suppl): S2.
8. Spenny J G, Brown M. Effects of acetylsalicylic acid on gastric mucosa. ii. Mucosal ATP and phosphocreatine content and salicylic effects on mitochondrial metabolism. Gastroenterology 1977; 73: 995-9.
9. Meza I G, Ibarra G, Sabenero M, Martinez-Palamo A, Cereijido M. Occluding junctions and cyto-skeletal components in a cultured transporting epithelium. J Cell Biol 1980; 87: 746-54.
10. Roberts A. Cytoprotection by prostaglandins. Gastroenterology 1969; 77: 761.
11. Bjarnason I, Smethurst P, Fenn G C, Menzies I S, Levi A J. Misoprostol reduces indomethacin induced changes in human small intestinal permeability. Dig Dis Sci 1989; 34: 407-11.
12. Bjarnason I, William P, Smethhurst P, Peters T, Levi A J. The effect of NSAIDs and prostaglandins on the permeability of human intestine. Gut 1986; 27: 1292-7.
13. Hayllar J, Macpherson A, Bjarnason I. Gastroprotection and anti-inflammatory drugs (NSAIDs) rational and clinical implications. Drug Safety 1992; 7: 86-105.
14. Scheiman J M, Behler E M, Loeffler K M, Elta G H. Omeprazole ameliorates aspirin-induced gastro-duodenal injury. Dig Dis Sci 1994; 39: 97-103.
15. Taha A S, Nakshaeene D, Lee F D, Sturreck R D, Russell R I. Chemical gastritis and Helicobacter pylori related gastritis in patients receiving NSAIDs: comparison and correlation with peptic ulceration. J Chem Pathol 1992; 45: 135-9.
16. Melarange R, Moore G, Blower P R, Coates M E, Ward F W, Ronaasen V. A comparison of indomethacin with ibuprofen on gastro-intestinal mucosal integrity on conventional and germ free rats. Aliment Pharmacol Ther 1992; 6: 67-77.
17. Fang W-F, Broughton A, Jacobson E D. Indomethacin-induced intestinal inflammation. Dig Dis Sci 1977; 22: 187-90.
18. Satoh H, Guth P H, Grossman M I. Role of bacteria in gastric ulceration produced by indomethacin in the rat: cyto-protective action of antibiotics. Gastroenterology 1983; 84: 483-9.
19. Wallace J L, Keenan C M, Granger D N. Gastric ulceration induced by non-steroidal anti-inflammatory drugs is a neutrophil dependent process. Am J Physiol 1990; 259: G462-7.
20. Wallace J L, Arfors K E, McKnight G W. A monoclonal antibody against the CD 18 leucocyte adhesion molecule prevents indomethacin induced gastric damage in rabbit. Gastroenterology 1991; 100: 878-83.
21. Vane J R, Botting R. Inflammation and the mechanism of action of anti-inflammatory drugs. FASEB J 1987; 1: 89-96.
22. Levine R A, Petokas S, Nandi J, Enthoven D. Effects of non-steroidal anti-inflammatory drugs on gastro-intestinal injury and prostanoid generation in healthy volunteers. Dig Dis Sci 1988; 33: 660-6.
23. Whittle B J R. Temporal relationship between cyclo-oxygenase inhibition, as measured by prostacyclin biosynthesis, and gastro-intestinal damage induced by indomethacin in the rat. Gastroenterology 1981; 80: 94-8.
24. Ligumski M, Golanska E M, Hansen D G, Kauffman G L. Aspirin can inhibit gastric mucosal cyclo-oxygenase without causing lesions in the rat. Gastroenterology 1983; 84: 756-61.
25. Baskin W N, Ivey K J, Krausz W J, et al. Aspirin-induced utrastructural changes in human gastric mucosa. Ann Intern Med 1976; 85: 292-303.
26. Whitehouse M W. Biochemical properties of anti-inflammatory drugs-III. Uncoupling of oxidative phosphorylation in a connective tissue (cartilage) and liver mitochondria by salicyclate analogues: relationship of structure to activity. Biochem Pharmacol 1964; 13: 319-36.
27. Mahmud T, Wrigglesworth J M, Rafi S, Scott D L, Bjarnason I. Uncoupling of oxidative phosphorylation by non-steroidal anti-inflammatory drugs (NSAIDs) is related to ionizable moiety and can be altered by modification of carboxylic group. Arthritis Rheum 1995; 38 (suppl): S207.
28. Wallace J L, Reuter B, Cicala C, McKnight W, Grisham M B, Cirino G. Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology 1994; 107: 173-90.
29. Elliott S N, McKnight W, Cirino G, Wallace J L. A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology 1995; 109: 524-30.
30. Melarange R, Gentry C, O'Connell C, et al. Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-naphthylacetic acid (6MNA). Comparative studies with indomethacin. Dig Dis Sci 1992; 37: 1847-52.
31. Gierse J K, Hauser S D, Creely D P, Koboldt C, Rangwala S H, Isakson P C. Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem J 1995; 305: 479-84.